Canaccord Genuity Maintains Merit Medical Systems at Buy, Raises Target to $121
Canaccord Genuity raised its price target from $94 to $121, a 28.7% increase. The new target implies 40.3% upside from the Oct. 30 close of $86.24.
Canaccord Genuity raised its price target from $94 to $121, a 28.7% increase. The new target implies 40.3% upside from the Oct. 30 close of $86.24.